147 related articles for article (PubMed ID: 20348150)
1. EBV-positive B cell cerebral lymphoma 12 years after sex-mismatched kidney transplantation: post-transplant lymphoproliferative disorder or donor-derived lymphoma?
Phelan PJ; Murphy RK; Farrell M; O'Toole O; Heffernan J; O'Brien D; Breathnach O; Conlon PJ
Nephrol Dial Transplant; 2010 Jun; 25(6):2032-5. PubMed ID: 20348150
[TBL] [Abstract][Full Text] [Related]
2. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G
Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
[TBL] [Abstract][Full Text] [Related]
3. Post-transplantation lymphoproliferative disorder of donor origin in a sex-mismatched renal allograft as proven by chromosome in situ hybridization.
Cheung AN; Chan AC; Chung LP; Chan TM; Cheng IK; Chan KW
Mod Pathol; 1998 Jan; 11(1):99-102. PubMed ID: 9556430
[TBL] [Abstract][Full Text] [Related]
4. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW
Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
[TBL] [Abstract][Full Text] [Related]
5. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Weiss LM; Shintaku IP; Said JW
Arch Pathol Lab Med; 1997 Jul; 121(7):701-6. PubMed ID: 9240905
[TBL] [Abstract][Full Text] [Related]
6. EBV lymphoproliferative disease of host origin after haploidentical stem cell transplantation.
Kasow KA; Leung W; Horwitz EM; Woodard P; Handgretinger R; Hale GA
Pediatr Blood Cancer; 2007 Nov; 49(6):869-72. PubMed ID: 16421900
[TBL] [Abstract][Full Text] [Related]
7. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
[TBL] [Abstract][Full Text] [Related]
8. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
[TBL] [Abstract][Full Text] [Related]
9. Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for myelodysplastic syndrome.
Ho AY; Adams S; Shaikh H; Pagliuca A; Devereux S; Mufti GJ
Bone Marrow Transplant; 2002 May; 29(10):867-9. PubMed ID: 12058237
[TBL] [Abstract][Full Text] [Related]
10. In situ hybridization for the Y chromosome reveals a donor origin for a posttransplant lymphoproliferative disorder in a sex-mismatched hepatic allograft.
Hegele RG; Bicknell SG; Bailey DJ; Cameron RG
Arch Pathol Lab Med; 1994 Aug; 118(8):795-6. PubMed ID: 8060227
[TBL] [Abstract][Full Text] [Related]
11. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G
J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous presentation of post-renal transplant lymphoproliferative disorder: a series of four cases.
Salama S; Todd S; Cina DP; Margetts P
J Cutan Pathol; 2010 Jun; 37(6):641-53. PubMed ID: 19903218
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
[TBL] [Abstract][Full Text] [Related]
15. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Transpl Infect Dis; 2009 Oct; 11(5):393-9. PubMed ID: 19497070
[TBL] [Abstract][Full Text] [Related]
16. Epstein--Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin.
Verma S; Frambach GE; Seilstad KH; Nuovo G; Porcu P; Magro CM
J Cutan Pathol; 2005 Aug; 32(7):474-83. PubMed ID: 16008691
[TBL] [Abstract][Full Text] [Related]
17. [Virus, immunosuppression, and the kidney transplant recipient].
Alberú J; Villasís A
Rev Invest Clin; 2005; 57(4):582-95. PubMed ID: 16315643
[No Abstract] [Full Text] [Related]
18. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K
Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054
[TBL] [Abstract][Full Text] [Related]
19. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
20. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
